Progress in the prevention of GVH: bone marrow grafts after ALG conditioning, with lymphocyte split chimerism, use of a lymphocyte "chalone T", and soluble histocompatibility antigens.
D000741:Anemia, Aplastic / Q000276:immunology; D000818:Animals; D000961:Antilymphocyte Serum / Q000494:pharmacology*; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D006087:Graft vs Host Reaction; D006131:Growth Inhibitors / Q000494:pharmacology*; D006649:Histocompatibility Antigens; D006801:Humans; D017710:Lymphocyte Transfusion; D008214:Lymphocytes / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D009030:Mosaicism; D011828:Radiation Chimera; D016038:Skin Transplantation; D012995:Solubility; D013601:T-Lymphocytes / Q000276:immunology*; D013950:Thymus Gland / Q000166:cytology; D014020:Tissue Extracts; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D006131:Growth Inhibitors; D006649:Histocompatibility Antigens; D014020:Tissue Extracts